115 related articles for article (PubMed ID: 31326598)
1. A mitochondrial delivery system using liposome-based nanocarriers that target myoblast cells.
Katayama T; Kinugawa S; Takada S; Furihata T; Fukushima A; Yokota T; Anzai T; Hibino M; Harashima H; Yamada Y
Mitochondrion; 2019 Nov; 49():66-72. PubMed ID: 31326598
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial transgene expression via an artificial mitochondrial DNA vector in cells from a patient with a mitochondrial disease.
Ishikawa T; Somiya K; Munechika R; Harashima H; Yamada Y
J Control Release; 2018 Mar; 274():109-117. PubMed ID: 29408532
[TBL] [Abstract][Full Text] [Related]
3. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter.
Yamada Y; Harashima H
Biomaterials; 2012 Feb; 33(5):1589-95. PubMed ID: 22105068
[TBL] [Abstract][Full Text] [Related]
4. [Development of the MITO-porter, a nano device for mitochondrial drug delivery via membrane fusion].
Yamada Y
Yakugaku Zasshi; 2014; 134(11):1143-55. PubMed ID: 25366911
[TBL] [Abstract][Full Text] [Related]
5. [MITO-Porter; a cutting-edge technology for mitochondrial gene therapy].
Furukawa R; Yamada Y; Harashima H
Yakugaku Zasshi; 2012; 132(12):1389-98. PubMed ID: 23208046
[TBL] [Abstract][Full Text] [Related]
6. Effects of myogenin on muscle fiber types and key metabolic enzymes in gene transfer mice and C2C12 myoblasts.
Zhu LN; Ren Y; Chen JQ; Wang YZ
Gene; 2013 Dec; 532(2):246-52. PubMed ID: 24055422
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial delivery of Coenzyme Q10 via systemic administration using a MITO-Porter prevents ischemia/reperfusion injury in the mouse liver.
Yamada Y; Nakamura K; Abe J; Hyodo M; Haga S; Ozaki M; Harashima H
J Control Release; 2015 Sep; 213():86-95. PubMed ID: 26160304
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Delivery of an Anticancer Drug Via Systemic Administration Using a Mitochondrial Delivery System That Inhibits the Growth of Drug-Resistant Cancer Engrafted on Mice.
Yamada Y; Munechika R; Satrialdi ; Kubota F; Sato Y; Sakurai Y; Harashima H
J Pharm Sci; 2020 Aug; 109(8):2493-2500. PubMed ID: 32376272
[TBL] [Abstract][Full Text] [Related]
9. Glutamine depletion disrupts mitochondrial integrity and impairs C2C12 myoblast proliferation, differentiation, and the heat-shock response.
Dohl J; Passos MEP; Foldi J; Chen Y; Pithon-Curi T; Curi R; Gorjao R; Deuster PA; Yu T
Nutr Res; 2020 Dec; 84():42-52. PubMed ID: 33189431
[TBL] [Abstract][Full Text] [Related]
10. Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery.
Yamada Y; Furukawa R; Yasuzaki Y; Harashima H
Mol Ther; 2011 Aug; 19(8):1449-56. PubMed ID: 21694702
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Mitochondrial Genome Via a MITO-Porter : Evaluation of mtDNA and mtRNA Levels and Mitochondrial Function.
Yamada Y; Harashima H
Methods Mol Biol; 2021; 2275():227-245. PubMed ID: 34118041
[TBL] [Abstract][Full Text] [Related]
12. P43-dependent mitochondrial activity regulates myoblast differentiation and slow myosin isoform expression by control of Calcineurin expression.
Seyer P; Grandemange S; Rochard P; Busson M; Pessemesse L; Casas F; Cabello G; Wrutniak-Cabello C
Exp Cell Res; 2011 Aug; 317(14):2059-71. PubMed ID: 21664352
[TBL] [Abstract][Full Text] [Related]
13. Activation of Mitochondrial Oxygen Consumption Rate by Delivering Coenzyme Q
Sato I; Hibino M; Takeda A; Harashima H; Yamada Y
J Pharm Sci; 2024 Jul; 113(7):1836-1843. PubMed ID: 38325738
[TBL] [Abstract][Full Text] [Related]
14. Role of the α2 subunit of AMP-activated protein kinase and its nuclear localization in mitochondria and energy metabolism-related gene expressions in C2C12 cells.
Okamoto S; Asgar NF; Yokota S; Saito K; Minokoshi Y
Metabolism; 2019 Jan; 90():52-68. PubMed ID: 30359677
[TBL] [Abstract][Full Text] [Related]
15. Mitsugumin 53 promotes mitochondrial autophagy through regulating Ambra1 expression in C2C12 myoblast cells.
Lijie G; Yueyue Z; Nan Z; Ling W; Xuan W; Weijie Y
Cell Biol Int; 2019 Mar; 43(3):290-298. PubMed ID: 30614598
[TBL] [Abstract][Full Text] [Related]
16. Intracellular observation of nanocarriers modified with a mitochondrial targeting signal peptide.
Kawamura E; Yamada Y; Yasuzaki Y; Hyodo M; Harashima H
J Biosci Bioeng; 2013 Nov; 116(5):634-7. PubMed ID: 23735326
[TBL] [Abstract][Full Text] [Related]
17. Targeting the mitochondrial genome via a dual function MITO-Porter: evaluation of mtDNA levels and mitochondrial function.
Yamada Y; Harashima H
Methods Mol Biol; 2015; 1265():123-33. PubMed ID: 25634272
[TBL] [Abstract][Full Text] [Related]
18. Dietary isoflavone daidzein promotes Tfam expression that increases mitochondrial biogenesis in C2C12 muscle cells.
Yoshino M; Naka A; Sakamoto Y; Shibasaki A; Toh M; Tsukamoto S; Kondo K; Iida K
J Nutr Biochem; 2015 Nov; 26(11):1193-9. PubMed ID: 26166229
[TBL] [Abstract][Full Text] [Related]
19. Validation of the use of an artificial mitochondrial reporter DNA vector containing a Cytomegalovirus promoter for mitochondrial transgene expression.
Yamada Y; Ishikawa T; Harashima H
Biomaterials; 2017 Aug; 136():56-66. PubMed ID: 28521201
[TBL] [Abstract][Full Text] [Related]
20. The use of a MITO-Porter to deliver exogenous therapeutic RNA to a mitochondrial disease's cell with a A1555G mutation in the mitochondrial 12S rRNA gene results in an increase in mitochondrial respiratory activity.
Yamada Y; Maruyama M; Kita T; Usami SI; Kitajiri SI; Harashima H
Mitochondrion; 2020 Nov; 55():134-144. PubMed ID: 33035688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
